This secondary analysis of data from a randomized clinical trial of women treated with tamoxifen vs no systemic therapy and followed up for 2 decades investigates if a multigene classifier is associated with indolent behavior of invasive breast cancers.
http://ift.tt/2t5gYRJ
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου